~$130mm market cap biotech firm, with multiple products in the pipeline based on their patented Versamune nanoparticle platform.
Recently spiked on announcement of award of $60mm from Brazilian Ministry of Science & Technology to fund phase 1/2 clinical trials for a potential Covid vaccine based on their Verasmune platform.
Since the news, avg vol (10day) is...
